Our clinical trial has been on hold since July 2017 and we may not be successful at defining a clinical path
forward, and, even if we are, we may not be able to raise the funds to complete such clinical path
, either of which may cause us to curtail or cease operations.
InVivo does not anticipate reopening enrollment in INSPIRE and expects to provide additional clarity on its clinical path
forward in the second quarter of 2018.
For especially complicated procedures, surgical teams can even pause in the midst of their work to consult the EchoPixel imaging as confirmation they're still on the right clinical path
Here is a sample of the clinical scenarios in which we have seen inconsistencies between current practice and the best evidence in perinatal psychiatry or situations in which data are too sparse to inform the clearest clinical path
In the end, a combination of the tough market environment and long clinical path
ahead drove a financial/clinical failure," Maxim Group analyst Jason Kolbert writes in a note.
But "with cognitive computing, you can greatly, greatly, greatly shorten the amount of time it takes to develop a clinical path
, and you can rely on evidence from the charts of your patients," Snow states.
When a laboring woman is transferred from home to the hospital, a negotiation begins with the hospital professionals about the best clinical path
to a successful birth.
Dohmen, a privately-held, Life Science Services Company, has acquired three technology companies; Red Arrow Labs, Clinical Path
Consulting and ChemWare, according to CEO Cynthia (Dohmen) LaConte, it was reported yesterday.
The Company is now advancing the technology platform on an initial clinical path
as a treatment modality for breast cancers.
Whether we are talking about stress, depression, or recovery from stroke, a supportive group life plays a critical role in a person's clinical path
," she said.
Adoptive cell transfer: a clinical path
to effective cancer immunotherapy.
Keep in mind that in all of these cases the idea is to reduce risk incrementally in both technology and market while building a team that can move down the clinical path